140 related articles for article (PubMed ID: 38277657)
1. Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
Hua L; Alkhatib M; Fujio S; Alhasan B; Herold S; Zeugner S; Zolal A; Hijazi MM; Clark VE; Wakimoto H; Shankar GM; Brastianos PK; Barker FG; Cahill DP; Ren L; Eyüpoglu IY; Gong Y; Schackert G; Juratli TA
J Neurosurg; 2024 Jan; ():1-7. PubMed ID: 38277657
[TBL] [Abstract][Full Text] [Related]
2. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
[TBL] [Abstract][Full Text] [Related]
3. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic PI3K mutations are as common as AKT1 and SMO mutations in meningioma.
Abedalthagafi M; Bi WL; Aizer AA; Merrill PH; Brewster R; Agarwalla PK; Listewnik ML; Dias-Santagata D; Thorner AR; Van Hummelen P; Brastianos PK; Reardon DA; Wen PY; Al-Mefty O; Ramkissoon SH; Folkerth RD; Ligon KL; Ligon AH; Alexander BM; Dunn IF; Beroukhim R; Santagata S
Neuro Oncol; 2016 May; 18(5):649-55. PubMed ID: 26826201
[TBL] [Abstract][Full Text] [Related]
5. Genetic landscape of meningioma.
Yuzawa S; Nishihara H; Tanaka S
Brain Tumor Pathol; 2016 Oct; 33(4):237-247. PubMed ID: 27624470
[TBL] [Abstract][Full Text] [Related]
6. Genomic Analysis of Posterior Fossa Meningioma Demonstrates Frequent
Williams SR; Juratli TA; Castro BA; Lazaro TT; Gill CM; Nayyar N; Strickland MR; Babinski M; Johnstone SE; Frosch MP; Silverman IM; Ely HA; Kaplan AB; D'Andrea MR; Bihun IV; Hoang K; Batchelor E; Christiansen J; Cahill DP; Barker FG; Brastianos PK
J Neurol Surg B Skull Base; 2019 Dec; 80(6):562-567. PubMed ID: 31750041
[No Abstract] [Full Text] [Related]
7. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
[TBL] [Abstract][Full Text] [Related]
8. Intraventricular meningiomas frequently harbor NF2 mutations but lack common genetic alterations in TRAF7, AKT1, SMO, KLF4, PIK3CA, and TERT.
Jungwirth G; Warta R; Beynon C; Sahm F; von Deimling A; Unterberg A; Herold-Mende C; Jungk C
Acta Neuropathol Commun; 2019 Aug; 7(1):140. PubMed ID: 31470906
[TBL] [Abstract][Full Text] [Related]
9. Distinct genomic subclasses of high-grade/progressive meningiomas: NF2-associated, NF2-exclusive, and NF2-agnostic.
Williams EA; Santagata S; Wakimoto H; Shankar GM; Barker FG; Sharaf R; Reddy A; Spear P; Alexander BM; Ross JS; Brastianos PK; Cahill DP; Ramkissoon SH; Juratli TA
Acta Neuropathol Commun; 2020 Oct; 8(1):171. PubMed ID: 33087175
[TBL] [Abstract][Full Text] [Related]
10. Specific gene expression signatures of low grade meningiomas.
Tsitsikov EN; Hameed S; Tavakol SA; Stephens TM; Tsytsykova AV; Garman L; Bi WL; Dunn IF
Front Oncol; 2023; 13():1126550. PubMed ID: 36937440
[TBL] [Abstract][Full Text] [Related]
11.
Sakai Y; Miyawaki S; Teranishi Y; Okano A; Ohara K; Hongo H; Ishigami D; Shimada D; Mitsui J; Nakatomi H; Saito N
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804955
[TBL] [Abstract][Full Text] [Related]
12. Genomic analysis of non-NF2 meningiomas reveals mutations in TRAF7, KLF4, AKT1, and SMO.
Clark VE; Erson-Omay EZ; Serin A; Yin J; Cotney J; Ozduman K; Avşar T; Li J; Murray PB; Henegariu O; Yilmaz S; Günel JM; Carrión-Grant G; Yilmaz B; Grady C; Tanrikulu B; Bakircioğlu M; Kaymakçalan H; Caglayan AO; Sencar L; Ceyhun E; Atik AF; Bayri Y; Bai H; Kolb LE; Hebert RM; Omay SB; Mishra-Gorur K; Choi M; Overton JD; Holland EC; Mane S; State MW; Bilgüvar K; Baehring JM; Gutin PH; Piepmeier JM; Vortmeyer A; Brennan CW; Pamir MN; Kiliç T; Lifton RP; Noonan JP; Yasuno K; Günel M
Science; 2013 Mar; 339(6123):1077-80. PubMed ID: 23348505
[TBL] [Abstract][Full Text] [Related]
13. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
Youngblood MW; Duran D; Montejo JD; Li C; Omay SB; Özduman K; Sheth AH; Zhao AY; Tyrtova E; Miyagishima DF; Fomchenko EI; Hong CS; Clark VE; Riche M; Peyre M; Boetto J; Sohrabi S; Koljaka S; Baranoski JF; Knight J; Zhu H; Pamir MN; Avşar T; Kilic T; Schramm J; Timmer M; Goldbrunner R; Gong Y; Bayri Y; Amankulor N; Hamilton RL; Bilguvar K; Tikhonova I; Tomak PR; Huttner A; Simon M; Krischek B; Kalamarides M; Erson-Omay EZ; Moliterno J; Günel M
J Neurosurg; 2019 Oct; 133(5):1345-1354. PubMed ID: 31653806
[TBL] [Abstract][Full Text] [Related]
14. POLR2A Mutation is a Poor Prognostic Marker of Cerebellopontine Angle Meningioma.
Okano A; Miyawaki S; Teranishi Y; Hongo H; Dofuku S; Ohara K; Sakai Y; Shin M; Nakatomi H; Saito N
Neurosurgery; 2024 Feb; ():. PubMed ID: 38380947
[TBL] [Abstract][Full Text] [Related]
15. Secretory meningiomas are defined by combined KLF4 K409Q and TRAF7 mutations.
Reuss DE; Piro RM; Jones DT; Simon M; Ketter R; Kool M; Becker A; Sahm F; Pusch S; Meyer J; Hagenlocher C; Schweizer L; Capper D; Kickingereder P; Mucha J; Koelsche C; Jäger N; Santarius T; Tarpey PS; Stephens PJ; Andrew Futreal P; Wellenreuther R; Kraus J; Lenartz D; Herold-Mende C; Hartmann C; Mawrin C; Giese N; Eils R; Collins VP; König R; Wiestler OD; Pfister SM; von Deimling A
Acta Neuropathol; 2013 Mar; 125(3):351-8. PubMed ID: 23404370
[TBL] [Abstract][Full Text] [Related]
16. Genomic Landscape of Meningiomas.
Wang JZ; Nassiri F; Mawrin C; Zadeh G
Adv Exp Med Biol; 2023; 1416():137-158. PubMed ID: 37432625
[TBL] [Abstract][Full Text] [Related]
17. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
[TBL] [Abstract][Full Text] [Related]
18.
Kaidonis G; Pekmezci M; Van Ziffle J; Auguste KI; Horton JC
J Neurosurg Case Lessons; 2022 Jun; 3(23):CASE2247. PubMed ID: 35733823
[TBL] [Abstract][Full Text] [Related]
19. Association of frequent NF2 mutations with spinal location predominance and worse outcomes in psammomatous meningiomas.
Ren L; Xie Q; Deng J; Chen J; Yu J; Wang D; Wakimoto H; Gong Y; Hua L
J Neurosurg; 2024 Mar; ():1-9. PubMed ID: 38552238
[TBL] [Abstract][Full Text] [Related]
20. High-grade meningiomas: biology and implications.
Bi WL; Prabhu VC; Dunn IF
Neurosurg Focus; 2018 Apr; 44(4):E2. PubMed ID: 29606053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
